The global sulfadiazine sodium injection market is estimated to grow at a moderate CAGR during the forecast period. A sulfonamide antibiotic is sulfadiazine sodium. Injections of sulfadiazine sodium are used to treat a variety of bacterial infections, including those of the brain, ears, and urinary tract. It's also used to keep people who are at risk from being infected. Sulfadiazine is an antibacterial prescription drug approved by the US Food and Drug Administration (FDA) for the treatment of chancroid, Toxoplasma gondii encephalopathy, urinary tract infections, and other bacterial diseases.

Increasing awareness of safe antibiotic use is likely to create high demand for sulfadiazine sodium injection in the global market over the forecast period, owing to widespread antibiotic resistance. For example, every November, World Antibiotic Awareness Week (WAAW) attempts to raise global awareness of antibiotic resistance (AMR) and encourage best practices among the general public, health workers, and policymakers to avoid the emergence and spread of antibiotic resistance.

Bacterial pathogens have evolved resistance to the sulfonamide antibiotic class through time, either through alterations in pre-existing DNA or the acquisition of antibiotic resistance genes (ARGs). It is one of the hot acting sulfonamides used in combination with pyrimethamine which is likely to hinder the market of sulfachlorpyridazine sodium.  Toxoplasmosis is treated with it in AIDS patients and infants with congenital infections. It's a short-acting sulfonamide that's often used with pyrimethamine. Toxoplasmosis is treated with it in AIDS patients and infants with congenital infections. In veterinary animals such as cattle, sulfadiazine sodium injections are used to treat respiratory tract infections, genitourinary infections, alimentary tract infections, and sepsis.

Market Coverage

• The market number available for – 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segments Covered

o By Product Type

o By Patient Type

o By Indication

o By End-User

• Regions Covered

o North America

o Europe

o Asia-Pacific

o Rest of the world

• Competitive Landscape: Sichuan Chengkang, XINHUA PHARM, Square Pharmaceuticals, Jurox, Pfizer among others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominates the market in base year?
• Which segment and region will project fastest growth in the market?
• How COVID-19 impacted the market?

o Recovery Timeline

o Deviation from pre-COVID forecast

o Most affected region and segment

• Who is the leader in the market?
• How players are addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Sulfadiazine Sodium Injection Market by Segments,

By Product Type

• 20mg/mL
• 40mg/mL
• Others

By Patient Type

• Human
• Animal

By Indication

• Toxoplasmosis
• Acute Otitis Media (AOM)
• Chancroid
• Chlamydial Infections
• Haemophilus Influenzae Infections
• Malaria
• Neisseria Meningitides Infections
• Plague
• Urinary Tract Infections (UTIs)

By End-User

• Hospitals
• Clinics
• Medical Centers
• Veterinary

Global Sulfadiazine Sodium Injection Market by Region